Discontinued — last reported Q2 '21
Non-Current Assets
Investments - Amortized Cost Basis
Amgen Investments - Amortized Cost Basis increased by 34.7% to $11.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.3%, from $8.30B to $11.48B. Over 5 years (FY 2020 to FY 2025), Investments - Amortized Cost Basis shows an upward trend with a 111.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2017
Last reportedQ2 2021
Metric ID:
investments_amortized_costHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $245.00M | $255.00M | $262.00M | $261.00M | $280.00M | $227.00M | $4.34B | $31.07B | $33.62B | $34.21B | $10.40B | $9.24B | $8.81B | $8.58B | $11.49B | $8.30B | $7.49B | $8.71B | $8.53B | $11.48B |
| QoQ Change | — | +4.1% | +2.7% | -0.4% | +7.3% | -18.9% | >999% | +616.6% | +8.2% | +1.8% | -69.6% | -11.2% | -4.6% | -2.7% | +33.9% | -27.7% | -9.8% | +16.3% | -2.1% | +34.7% |
| YoY Change | — | — | — | — | +14.3% | -11.0% | >999% | >999% | >999% | >999% | +140.0% | -70.3% | -73.8% | -74.9% | +10.4% | -10.1% | -15.0% | +1.5% | -25.8% | +38.3% |
Range$227.00M – $34.21B
CAGR+124.8%
Avg YoY Growth>999%
Median YoY Growth+6.0%
Investments - Amortized Cost Basis at Other Companies
Frequently Asked Questions
- What is Amgen's investments - amortized cost basis?
- Amgen (AMGN) reported investments - amortized cost basis of $11.48B in Q1 2026.
- How has Amgen's investments - amortized cost basis changed year-over-year?
- Amgen's investments - amortized cost basis increased by 38.3% year-over-year, from $8.30B to $11.48B.
- What is the long-term trend for Amgen's investments - amortized cost basis?
- Over 5 years (2020 to 2025), Amgen's investments - amortized cost basis has grown at a 111.2% compound annual growth rate (CAGR), from $203.00M to $8.53B.